相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Triglyceride-lowering and anti-inflammatory mechanisms of omega-3 polyunsaturated fatty acids for atherosclerotic cardiovascular risk reduction
Qiyuan Keith Liu
JOURNAL OF CLINICAL LIPIDOLOGY (2021)
Omega-3 Versus Omega-6 Polyunsaturated Fatty Acids in the Prevention and Treatment of Inflammatory Skin Diseases
Anamaria Balic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Antithrombotic Treatment in Diabetes Mellitus: A Review of the Literature about Antiplatelet and Anticoagulation Strategies Used for Diabetic Patients in Primary and Secondary Prevention
Gerasimos Siasos et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
US life expectancy stalls due to cardiovascular disease, not drug deaths
Neil K. Mehta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk The STRENGTH Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol
Gregory A. Nichols et al.
DIABETES OBESITY & METABOLISM (2019)
Recombinant Human Erythropoietin Proteins Synthesized in Escherichia coli Cells: Effects of Additional Domains on the in vitro and in vivo Activities
A. S. Karyagina et al.
BIOCHEMISTRY-MOSCOW (2019)
Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities
Magnus Back et al.
NATURE REVIEWS CARDIOLOGY (2019)
A systematic review of the effects of increasing arachidonic acid intake on PUFA status, metabolism and health-related outcomes in humans
Philip C. Calder et al.
BRITISH JOURNAL OF NUTRITION (2019)
The Link between Hematopoiesis and Atherosclerosis
Menno P. J. de Winther et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
Carl E. Orringer et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants
Yang Hu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
JoAnn E. Manson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
ANICHKOV study: the effect of combined hypotensive and lipid-lowering therapy on cardiovascular complications in patients of high and very high risk
I. V. Sergienko et al.
TERAPEVTICHESKII ARKHIV (2019)
Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review
Ramesh Kumar Saini et al.
LIFE SCIENCES (2018)
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus
Louise Bowman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
Aruna D. Pradhan et al.
AMERICAN HEART JOURNAL (2018)
A healthy approach to dietary fats: understanding the science and taking action to reduce consumer confusion
Ann G. Liu et al.
NUTRITION JOURNAL (2017)
Cardiovascular Outcomes With Surgical Left Atrial Appendage Exclusion in Patients With Atrial Fibrillation Who Underwent Valvular Heart Surgery (from the National Inpatient Sample Database)
Ayman Elbadawi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
The impact of image resolution on computation of fractional flow reserve: coronary computed tomography angiography versus 3-dimensional quantitative coronary angiography
Lili Liu et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2016)
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies
Christie M. Ballantyne et al.
ATHEROSCLEROSIS (2016)
Resolvin E1 attenuates atherosclerosis in absence of cholesterol-lowering effects and on top of atorvastatin
Kanita Salic et al.
ATHEROSCLEROSIS (2016)
A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States
Sephy Philip et al.
JOURNAL OF MEDICAL ECONOMICS (2016)
Eicosapentaenoic acid inhibits glucose-induced membrane cholesterol crystalline domain formation through a potent antioxidant mechanism
R. Preston Mason et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia
Nobuaki Tanaka et al.
ATHEROSCLEROSIS (2014)
Eicosapentaenoic Acid Combined with Optimal Statin Therapy Improves Endothelial Dysfunction in Patients with Coronary Artery Disease
Kentaro Toyama et al.
CARDIOVASCULAR DRUGS AND THERAPY (2014)
Eicosapentaenoic Acid Protects against Palmitic Acid-Induced Endothelial Dysfunction via Activation of the AMPK/eNOS Pathway
Che-Hsin Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1-executive summary
Terry A. Jacobson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Eicosapentaenoic acid induces neovasculogenesis in human endothelial progenitor cells by modulating c-kit protein and PI3-K/Akt/eNOS signaling pathways
Shao-Chih Chiu et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2014)
Overview of Prescription Omega-3 Fatty Acid Products for Hypertriglyceridemia
Howard S. Weintraub
POSTGRADUATE MEDICINE (2014)
Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies
Harold E. Bays et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2013)
Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study
Eliot A. Brinton et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan - 2012 Version
Tamio Teramoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2013)
n-3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
Maria Carla Roncaglioni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
Christie M. Ballantyne et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Reactive Oxygen Species and Endothelial Function - Role of Nitric Oxide Synthase Uncoupling and Nox Family Nicotinamide Adenine Dinucleotide Phosphate Oxidases
Augusto C. Montezano et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2012)
The Role of Nitric Oxide on Endothelial Function
Dimitris Tousoulis et al.
CURRENT VASCULAR PHARMACOLOGY (2012)
Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events A Systematic Review and Meta-analysis
Evangelos C. Rizos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
Jackie Bosch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Plaque distribution patterns in left main trunk bifurcations: prediction of branch vessel compromise by multidetector row computed topography after percutaneous coronary intervention
Yoshitaka Goto et al.
EUROINTERVENTION (2012)
Eicosapentaenoic Acid Supplementation Changes Fatty Acid Composition and Corrects Endothelial Dysfunction in Hyperlipidemic Patients
Ken Yamakawa et al.
CARDIOLOGY RESEARCH AND PRACTICE (2012)
Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
Harold E. Bays et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Orally Administered Eicosapentaenoic Acid Induces Rapid Regression of Atherosclerosis Via Modulating the Phenotype of Dendritic Cells in LDL Receptor-Deficient Mice
Kenji Nakajima et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Eicosapentaenoic Acid and Regression of Atherosclerotic Lesions A Role for Dendritic Cells
Andrew C. Lau et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Atopy Risk in Infants and Children in Relation to Early Exposure to Fish, Oily Fish, or Long-Chain Omega-3 Fatty Acids: A Systematic Review
Lefkothea-Stella Kremmyda et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2011)
Add-on Therapy of EPA Reduces Oxidative Stress and Inhibits the Progression of Aortic Stiffness in Patients with Coronary Artery Disease and Statin Therapy: A Randomized Controlled Study
Akira Takaki et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2011)
Omega-3 Fatty Acids and Cardiovascular Disease Effects on Risk Factors, Molecular Pathways, and Clinical Events
Dariush Mozaffarian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability
Abbie L. Cawood et al.
ATHEROSCLEROSIS (2010)
Effects of Polyunsaturated Omega-3 Fatty Acids on Responsiveness to Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention The OMEGA-PCI (OMEGA-3 Fatty Acids After PCI to Modify Responsiveness to Dual Antiplatelet Therapy) Study
Grzegorz Gajos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
n-3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Daan Kromhout et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Fatty Acids and Immune Function: Relevance to Inflammatory Bowel Diseases
Philip C. Calder
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2009)
Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomized controlled trial
Sjurdur F. Olsen et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice
Miwa Matsumoto et al.
ATHEROSCLEROSIS (2008)
Fatty acid composition abnormalities in atopic disease: evidence explored and role in the disease process examined
A. Sala-Vila et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2008)
Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-β levels after fish oil supplementation of pregnant women
Susanne Krauss-Etschmann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases
Philip C. Calder
MOLECULAR NUTRITION & FOOD RESEARCH (2008)
Impact of lipid-lowering therapy with pitavastatin, a new HMG-CoA reductase inhibitor, on regression of coronary atherosclerotic plaque - A 3-dimensional intravascular ultrasound study
Hiroaki Takashima et al.
CIRCULATION JOURNAL (2007)
Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome
Noriko Satoh et al.
DIABETES CARE (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
Effects of long-term fenofibrate therapy on cardiovascular events among 9795 people with type 2 diabetes mellitus: The FIELD study, a randomised controlled trial
A. Keech
ATHEROSCLEROSIS SUPPLEMENTS (2006)
n-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored
PC Calder
CLINICAL SCIENCE (2004)
The influence of different combinations of γ-linolenic, stearidonic and eicosapentaenoic acids on the fatty acid composition of blood lipids and mononuclear cells in human volunteers
EA Miles et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2004)
Effects of HMG-CoA reductase inhibitors on endothelial function - Role of microdomains and oxidative stress
RP Mason et al.
CIRCULATION (2004)
Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: A randomized, controlled trial
JA Dunstan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial
F Thies et al.
LANCET (2003)
Dietary supplementation with γ-linolenic acid or fish oil decreases T lymphocyte proliferation in healthy older humans
F Thies et al.
JOURNAL OF NUTRITION (2001)
分享论文
